Drug: |
||||
---|---|---|---|---|
Trial Name: |
Safety And Efficacy Study Of Sunitinib Malate In Chinese Patients With Imatinib Resistant Or Intolerant Malignant Gastrointestinal Stromal Tumor (GIST)
|
|||
NCT#: |
||||
Conditions: |
Gastrointestinal Stromal Tumor |
|||
Status: |
Completed |
|||
Phase: |
4 |
Start Date 12/01/2008 |
Age of Trial (yrs) 15.3 |
|
Treatment Phase: |
Gleevec-resistant |
|||
Drug Category: |
KIT/PDGFRA inhibitor |
|||
Strategy: |
Block KIT |
|||
Trial Type: |
Specifically GIST and only GIST |
|||
Other Protocol IDs: |
A6181177 |
|||
Sponsor: |
Pfizer |
|||
Patient Contact: |
Pfizer Oncology Clinical Trial Information Service
1-877-369-9753
PfizerCancerTrials@emergingmed.com
Pfizer CT.gov Call Center
1-800-718-1021 |
|||
Contact email: |
||||
Contact Phone: |
||||
Randomized: |
||||
IV or Oral: |
Oral |
|||
Trial Notes: |
Trial Links |
Trial Results |
Name |
Address |
City |
State |
Zip |
Country |
Beijing |
100035 |
China |
|||
Beijing |
100071 |
China |
|||
Nanjing |
Jiangsu |
210002 |
China |
||
Beijing |
100021 |
China |